PNT - POINT Biopharma Global GAAP EPS of -$0.24 revenue of $4.87M August, 14 2023 09:44 AM POINT Biopharma Global Inc. 2023-08-14 09:44:20 ET POINT Biopharma Global press release ( NASDAQ: PNT ): Q2 GAAP EPS of -$0.24. Revenue of $4.87M. For further details see: POINT Biopharma Global GAAP EPS of -$0.24, revenue of $4.87M